about
An Epstein-Barr virus anti-apoptotic protein constitutively expressed in transformed cells and implicated in burkitt lymphomagenesis: the Wp/BHRF1 linkEpstein-Barr virus nuclear antigen 3C and prothymosin alpha interact with the p300 transcriptional coactivator at the CH1 and CH3/HAT domains and cooperate in regulation of transcription and histone acetylation.Epstein-Barr virus LMP1 blocks p16INK4a-RB pathway by promoting nuclear export of E2F4/5Two carboxyl-terminal activation regions of Epstein-Barr virus latent membrane protein 1 activate NF-kappaB through distinct signaling pathways in fibroblast cell linesThe Epstein-Barr virus G-protein-coupled receptor contributes to immune evasion by targeting MHC class I molecules for degradationStage-specific inhibition of MHC class I presentation by the Epstein-Barr virus BNLF2a protein during virus lytic cycle.Epstein-Barr virus infection of polarized epithelial cells via the basolateral surface by memory B cell-mediated transfer infection.A novel latent membrane 2 transcript expressed in Epstein-Barr virus-positive NK- and T-cell lymphoproliferative disease encodes a target for cellular immunotherapy.Epstein Barr virus entry; kissing and conjugation.Latent membrane protein 1 inhibits Epstein-Barr virus lytic cycle induction and progress via different mechanisms.Down-regulation of BLIMP1α by the EBV oncogene, LMP-1, disrupts the plasma cell differentiation program and prevents viral replication in B cells: implications for the pathogenesis of EBV-associated B-cell lymphomas.Suppression of the LMP2A target gene, EGR-1, protects Hodgkin's lymphoma cells from entry to the EBV lytic cycle.Burkitt's lymphoma: the Rosetta Stone deciphering Epstein-Barr virus biology.Modulation of B-cell endoplasmic reticulum calcium homeostasis by Epstein-Barr virus latent membrane protein-1.Epstein-Barr virus latent membrane protein 1 increases calcium influx through store-operated channels in B lymphoid cells.Deciphering the role of Epstein-Barr virus in the pathogenesis of T and NK cell lymphoproliferationsEpstein-Barr virus-coded BHRF1 protein, a viral homologue of Bcl-2, protects human B cells from programmed cell deathBurkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics.Nuclear factor kappa B-dependent activation of the antiapoptotic bfl-1 gene by the Epstein-Barr virus latent membrane protein 1 and activated CD40 receptor.Epstein-Barr virus evasion of CD8(+) and CD4(+) T cell immunity via concerted actions of multiple gene products.Targeting of MCL-1 kills MYC-driven mouse and human lymphomas even when they bear mutations in p53Restricted Epstein-Barr virus protein expression in Burkitt lymphoma is due to a different Epstein-Barr nuclear antigen 1 transcriptional initiation site.Immune responses to Epstein-Barr virus: molecular interactions in the virus evasion of CD8+ T cell immunityHuman cytotoxic T-cell responses against Epstein-Barr virus nuclear antigens demonstrated by using recombinant vaccinia viruses.Epstein-barr virus and the pathogenesis of T and NK lymphoma: a mystery unsolved.Herpesviruses placating the unwilling host: manipulation of the MHC class II antigen presentation pathway.Epigenetic and transcriptional changes which follow Epstein-Barr virus infection of germinal center B cells and their relevance to the pathogenesis of Hodgkin's lymphoma.Immunohistochemical demonstration of the Epstein-Barr virus-encoded latent membrane protein in paraffin sections of Hodgkin's disease.Epstein-Barr virus represses the FoxO1 transcription factor through latent membrane protein 1 and latent membrane protein 2AArginine Methyltransferases Are Regulated by Epstein-Barr Virus in B Cells and Are Differentially Expressed in Hodgkin's Lymphoma.The bfl-1 gene is transcriptionally upregulated by the Epstein-Barr virus LMP1, and its expression promotes the survival of a Burkitt's lymphoma cell lineEpstein-Barr virus LMP-1 natural sequence variants differ in their potential to activate cellular signaling pathways.The H3K27me3 demethylase, KDM6B, is induced by Epstein-Barr virus and over-expressed in Hodgkin's Lymphoma.The Epstein-Barr virus-encoded BILF1 protein modulates immune recognition of endogenously processed antigen by targeting major histocompatibility complex class I molecules trafficking on both the exocytic and endocytic pathwaysEpstein-Barr virus regulates STAT1 through latent membrane protein 1.STAT1 contributes to the maintenance of the latency III viral programme observed in Epstein-Barr virus-transformed B cells and their recognition by CD8+ T cells.Features distinguishing Epstein-Barr virus infections of epithelial cells and B cells: viral genome expression, genome maintenance, and genome amplification.Cyclical expression of EBV latent membrane protein 1 in EBV-transformed B cells underpins heterogeneity of epitope presentation and CD8+ T cell recognition.The DNase of gammaherpesviruses impairs recognition by virus-specific CD8+ T cells through an additional host shutoff function.Epstein-Barr virus induces a distinct form of DNA-bound STAT1 compared with that found in interferon-stimulated B lymphocytes.
P50
Q21131584-C661A9C5-9B2B-4FD7-86A7-BFEACB969835Q24537547-78E4726B-C54B-4259-9879-AC838EBD07D0Q24675583-01C6837E-988E-4390-A474-E326FAF760D2Q28565703-0986497D-4454-46B5-BF84-FFBCD1FE3A3CQ33396983-5BDA0FCE-0F70-4090-BB57-7728F8D904F8Q33474804-D9C5B7BF-7D13-4B0C-BADA-242105DF3EEBQ33900772-E8887500-FE2D-44D4-AE0D-E385FBE6A669Q34310840-D85E0169-AAEB-4335-8B51-BED18A4D0062Q34405443-A9A88C97-1505-43C7-8750-252C9FA4BF6DQ34532370-1637ECE3-FF1D-4021-81D2-7D821BE5F7EAQ34627655-B3F92BE5-D1BE-4200-969C-78B86C21ED3BQ34650591-EFE98B14-46A2-4D4B-B79C-61038D8D09CFQ34658852-60190EB3-F4E0-44F2-A820-41F62E48F309Q34992494-B0B1C77B-6C3D-4C52-957C-AE32D803269AQ34998074-1111D3B4-EC9B-4481-8DA3-B40A0C0978BDQ35232848-499AEF21-07A4-4805-AD93-D37E843EF058Q36535182-690657D4-B99A-4ABE-B2F0-3B1BEC70A3BCQ36721503-5F070B0A-8916-47C9-99B1-5E0A364D996AQ36961875-57A1AF75-8EFC-43C9-9FD8-03BE76F1DA58Q37314721-2A606F2B-F13F-4CFD-9090-1AADC375E9C2Q37488736-2F43345F-3197-4709-8127-9129D8EDECECQ37552683-918EB83B-DCD0-40A8-B696-01881CBFBA08Q37652046-5FA89132-4739-45F4-B70F-D32B2DADA891Q37737223-9311BE88-EC9F-40F2-BB9D-7581CFD1B0E4Q38043974-1D1B4DDA-A185-4D81-B6B7-3CD33ACDE0C9Q38046606-54220086-079C-4745-A4FB-9C80CFC5FF4AQ38286091-DD109588-E056-45E2-8FA8-8B5CEDB81A97Q38488345-CAD66A3E-1BC7-4DFA-A928-2F2A46C56BA4Q39304933-95C04BEE-C5A1-4A9E-91E5-B9BDD3E5F3AFQ39419855-56D247C1-3B19-45A9-80CE-9CEC34DD1915Q39592173-0C2AEEF9-42CC-4392-90D8-46E3A3C81F41Q39604074-16471526-3125-401F-81AD-1AE37DD4AA71Q39606643-BB8101A1-2661-4390-B1BB-6DAD2715FF63Q39625133-E886C3AE-87DB-4005-98F1-31E88170B70CQ39736747-1B861D22-D96B-41ED-B99E-7915979434E1Q39851988-590247A6-F3AB-48F3-8A25-469B3B0A3958Q39852028-D1D2A76A-3554-4B4C-971F-0D10CB6EA60BQ39886068-B848E0BF-A59F-4AD5-9515-0671593F65D7Q40033016-ED32181F-E491-4BAB-AF5C-E2DEC9890E07Q40122923-D6573B75-EDF5-4177-A796-12D9EB9BECFA
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Martin Rowe
@ast
Martin Rowe
@en
Martin Rowe
@es
Martin Rowe
@nl
Martin Rowe
@sl
type
label
Martin Rowe
@ast
Martin Rowe
@en
Martin Rowe
@es
Martin Rowe
@nl
Martin Rowe
@sl
prefLabel
Martin Rowe
@ast
Martin Rowe
@en
Martin Rowe
@es
Martin Rowe
@nl
Martin Rowe
@sl
P1053
B-2880-2009
P106
P21
P31
P3829
P496
0000-0003-4139-7326